Artikel ; Online: Macrophage reprogramming for therapy.
2021 Band 163, Heft 2, Seite(n) 128–144
Abstract: Dysfunction of the immune system underlies a plethora of human diseases, requiring the development of immunomodulatory therapeutic intervention. To date, most strategies employed have been focusing on the modification of T lymphocytes, and although ... ...
Abstract | Dysfunction of the immune system underlies a plethora of human diseases, requiring the development of immunomodulatory therapeutic intervention. To date, most strategies employed have been focusing on the modification of T lymphocytes, and although remarkable improvement has been obtained, results often fall short of the intended outcome. Recent cutting-edge technologies have highlighted macrophages as potential targets for disease control. Macrophages play central roles in development, homeostasis and host defence, and their dysfunction and dysregulation have been implicated in the onset and pathogenesis of multiple disorders including cancer, neurodegeneration, autoimmunity and metabolic diseases. Recent advancements have led to a greater understanding of macrophage origin, diversity and function, in both health and disease. Over the last few years, a variety of strategies targeting macrophages have been developed and these open new therapeutic opportunities. Here, we review the progress in macrophage reprogramming in various disorders and discuss the potential implications and challenges for macrophage-targeted approaches in human disease. |
---|---|
Mesh-Begriff(e) | Animals ; Autoimmune Diseases/immunology ; Autoimmune Diseases/therapy ; Cell Differentiation ; Cellular Reprogramming ; Humans ; Immunotherapy/trends ; Macrophages/immunology ; Metabolic Diseases/immunology ; Metabolic Diseases/therapy ; Neoplasms/immunology ; Neoplasms/therapy ; Neurodegenerative Diseases/immunology ; Neurodegenerative Diseases/therapy |
Sprache | Englisch |
Erscheinungsdatum | 2021-01-25 |
Erscheinungsland | England |
Dokumenttyp | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
ZDB-ID | 80124-0 |
ISSN | 1365-2567 ; 0019-2805 ; 0953-4954 |
ISSN (online) | 1365-2567 |
ISSN | 0019-2805 ; 0953-4954 |
DOI | 10.1111/imm.13300 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Ud II Zs.181: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.